Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia

Am J Hematol. 2017 Jun;92(6):E88-E91. doi: 10.1002/ajh.24705. Epub 2017 Mar 20.

Authors

Michele P Lambert^{1

2}, Char M Witmer^{1

2}, Janet L Kwiatkowski^{1

2}

Affiliations

¹ Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
² Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

PMID: 28240793
DOI: 10.1002/ajh.24705

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Anemia, Iron-Deficiency / blood
Anemia, Iron-Deficiency / chemically induced*
Benzoates / adverse effects*
Benzoates / chemistry
Benzoates / therapeutic use
Drug Therapy, Combination
Female
Ferritins / blood
Humans
Hydrazines / adverse effects*
Hydrazines / chemistry
Hydrazines / therapeutic use
Iron / metabolism
Iron Chelating Agents / adverse effects*
Iron Chelating Agents / chemistry
Iron Chelating Agents / therapeutic use
Male
Molecular Structure
Platelet Count
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Pyrazoles / adverse effects*
Pyrazoles / chemistry
Pyrazoles / therapeutic use
Receptors, Fc / therapeutic use
Recombinant Fusion Proteins / therapeutic use
Thrombopoietin / therapeutic use
Young Adult

Substances

Benzoates
Hydrazines
Iron Chelating Agents
Pyrazoles
Receptors, Fc
Recombinant Fusion Proteins
Ferritins
Thrombopoietin
Iron
romiplostim
eltrombopag